Company: OSRH
Filing Date: 2025-06-23
Form Type: 424B3
Source: 0001213900-25-056351
Chunk: 105

Company: OSR Holdings, Inc.
Filing Date: 2025-06-23
Form: 424B3
Chunk 105
---
., Ltd. (2020-2021),
Head of Legal at Korea Investment Corporation (2016-2019), Head of Legal at National Pension Service (2013-2016), and Head of Legal at
Woori Asset Management Company (2011-2013). His earlier career also includes positions at Joowon (a Korean law firm, 2009-2011);
Biomass Korea (former KOSDAQ listed company, 2008-2009), Franklin Templeton Investment Management Co., Ltd. (a wholly-owned subsidiary
of Franklin Resources, Inc., a NYSE-listed company 2002-2007), and Accenture (a NYSE-listed company 2000-2002). Mr. Lee
earned a BA in Psychology from Korea University (1992), an MBA from Haas School of Business, University of California at Berkeley (1995),
and a JD from Syracuse University College of Law (1999) with a final year at Georgetown University Law Center in Washington, D.C. Mr. Lee
is well qualified to serve as Lead Director because of his membership in the New York State Bar and extensive experience in both
legal and investment sectors across various asset classes, demonstrating significant expertise in capital markets.

Dr. Alcide Barberishas
been a Director of the Company as of the Closing of the Business Combination. He is a biotech entrepreneur, Board Member and Executive
with over 25 years of management experience in the biotechnology industry, and scientific experience in the private and public research
sectors. He is currently CEO & Director of Mabylon AG (since 2017). Before joining Mabylon, he was CEO & President
of Humabs BioMed, now a subsidiary of VIR Biotechnology (2013-2016). His career has included senior positions at entrepreneurial
startups (Co-Founder of ESBATech AG (1998) and Oncalis AG (2006) and senior Executive Management, R&D Management and Business Development
positions. He has been member of the Board of Directors of ESBATech (now a Novartis company, 1998-2004), Oncalis (2006-2012) and EffRx
Pharmaceuticals (2016-2023), and he is currently (since March 2023) on the Board of Directors of Ontrack Biomedical. From 2016 through
2021 he was also Coordinator of the Startup Promotion Center of the University of Sv